A new trading day began on Friday, with Ventyx Biosciences Inc (NASDAQ: VTYX) stock price up 16.36% from the previous day of trading, before settling in for the closing price of $2.14. VTYX’s price has ranged from $1.67 to $11.48 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 36.44%. With a float of $52.89 million, this company’s outstanding shares have now reached $70.67 million.
In an organization with 80 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -4.74%, operating margin of -15258.18%, and the pretax margin is -14175.09%.
Ventyx Biosciences Inc (VTYX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Ventyx Biosciences Inc is 25.23%, while institutional ownership is 63.96%. The most recent insider transaction that took place on Dec 27 ’24, was worth 49,841. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 21,119 shares at a rate of $2.36, taking the stock ownership to the 464,582 shares. Before that another transaction happened on Dec 27 ’24, when Company’s Officer proposed sale 21,119 for $2.36, making the entire transaction worth $49,842.
Ventyx Biosciences Inc (VTYX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 36.44% per share during the next fiscal year.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Here are Ventyx Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 23.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.37, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -2.01 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Let’s dig in a bit further. During the last 5-days, its volume was 2.1 million. That was inferior than the volume of 2.2 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 39.14%. Additionally, its Average True Range was 0.21.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 47.67%, which indicates a significant decrease from 84.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.33% in the past 14 days, which was higher than the 84.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.28, while its 200-day Moving Average is $3.02. However, in the short run, Ventyx Biosciences Inc’s stock first resistance to watch stands at $2.65. Second resistance stands at $2.82. The third major resistance level sits at $3.07. If the price goes on to break the first support level at $2.23, it is likely to go to the next support level at $1.98. The third support level lies at $1.81 if the price breaches the second support level.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
With a market capitalization of 204.87 million, the company has a total of 70,711K Shares Outstanding. Currently, annual sales are 0 K while annual income is -192,960 K. The company’s previous quarter sales were 0 K while its latest quarter income was -35,250 K.
